GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,705 Cr | ₹1,659 Cr | ₹1,160 Cr | ₹1,412 Cr | ₹1,139 Cr |
What is the latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹1,659 Cr |
| Mar2023 | ₹1,160 Cr |
| Mar2022 | ₹1,412 Cr |
| Mar2021 | ₹1,139 Cr |
How is Cash and Bank of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,705 Cr | 2.76 | |
| Mar2024 | ₹1,659 Cr | 43.02 | |
| Mar2023 | ₹1,160 Cr | -17.80 | |
| Mar2022 | ₹1,412 Cr | 23.91 | |
| Mar2021 | ₹1,139 Cr | - | |
Compare Cash and Bank of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,916.1 Cr | 3.8% | -1.5% | 44.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3.8% |
-1.5% |
44.3% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses